Alcon, one or the world's largest manufacturer of eye care product maker Alocon likes to centralised drug facilities in Singapore, marked the commencement of construction of its first pharmaceutical manufacturing plant in the Asian region yesterday with a groundbreaking ceremony in Singapore's Tuas Biomedical Park.
The new 330,000 square foot plant will not only manufacture sight-saving pharmaceutical products for Asian markets, but also will create several new job opportunities.
The plant is expected to be complete in 2012. Previousl the Swiss company announced its plans to build the plant in April 2008.
Alcon believes that the location and capacity expansion will allow it to move more effectively and efficiently to meet the eye care needs of patients and eye care professionals across Asia with treatments for glaucoma, eye infections, eye inflammation and dry eyes.